Prothena | PRTA - Aktuelle Verpflichtungen

Aktienkurs
10.50
Täglich Wechseln
-0.08 -0.76%
Monatlich
9.60%
Jährlich
2.74%
Q2 Prognose
10.19




Aktuelle Verpflichtungen Veränderung Datum
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Agios Pharmaceuticals USD 82.21M 7.45M 2025-12
Akebia Therapeutics USD 162.94M 29.56M 2025-12
ALKERMES USD 543.44M 69.08M 2025-12
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Amgen USD 25.49B 3.7B 2025-12
Biogen USD 3.35B 59.4M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Exelixis USD 405.64M 31.86M 2025-12
Immunic USD 30.08M 2.77M 2025-09
Incyte USD 1.52B 176.44M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
MacroGenics USD 43.11M 1.36M 2025-12
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Prothena USD 40.84M 10.59M 2025-12
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12
Xoma USD 28.3M 6.81M 2025-09